Overall, we still see the #psychedelics sector spinning its wheels.
Market conditions remain poisonous for most of these stocks. Corrupt governments (dealing with out-of-control mental health crises) remain lethargic in pushing through necessary legal reforms.
$PSYK $PSIL
Then there is $MNMD...
https://t.co/ejGOudJZlt
I'm still holding most of my shares here, but if the ship doesn't get righted soon, will have to review the situation.
$MMED $MMQ
I'm disappointed (but not totally surprised) that the Field Trip/Reunion Neuroscience hasn't been accretive for shareholders. I didn't see this as a good time for #psychedelics entities to be making themselves smaller.
Been really busy these past few weeks with other projects, but thought I would check in with a quick update.
Just noticed that $GHRS is the new market cap leader in the space, edging out both $ATAI and $CMPS.
$NUMI and $SEEL getting some traction lately.
#psychedelicstocks
Subtitle:
"Psychedelic drugs and therapy are fueling the conversations on potentially revolutionary treatment and a paradigm shift for mental health disorders."
Looks like they are finally starting to get it. π
How the Psychedelics Industry Is Taking on the Future
The mainstream media is finally starting to catch up to the content we were already producing in early 2020. π
#psychedelics#psychedelicstocks $PSYK $PSIL #shroomstocks https://t.co/jnjL5xeqKv
$DRUG powers higher today (+72.80%) despite the strong selloff in markets. Another mega-volume day: 82+ million.
More of a "tug-of-war" day for $MNMD: volume (on the NASDAQ) 57+ million, but relatively unchanged in price (-1.50%).
#psychedelicstocks $MMED #shroomstocks
An unfortunate day to follow up yesterday's general bounce for the sector and insane feeding frenzies on $MNMD and $DRUG.
Due to technical imbalances in the options market, this is creating a strong downward bias across equity classes and global markets.
#psychedelicstocks
We saw elevated volume (and smaller bumps in share price) for several other players across the #psychedelics space today.
It will be very interesting to see what happens when markets open on Friday. π
The OTHER feeding frenzy on the day was $DRUG.
An even bigger bounce (+135.87%) on even heavier volume, by dollar value: 119 million shares.
Obviously, $DRUG (and many others) were way overdue for such a corrective bounce.
#psychedelicstocks#shroomstocks $PSYK $PSIL
@iamacalderon Lol! I've been really busy this week with other projects, so wasn't even looking at markets until after hours -- when I heard about $MNMD.
A little slow getting today's main market action, but the numbers speak for themselves.
$MNMD +36.18%
NASDAQ volume: 224+ million shares.
Calling that "a feeding frenzy" would be a bit of an understatement (lol).
#psychedelicstocks#psychedelics#shroomstocks $MMED $MMQ
@Dolphins19845 What's really crazy is that a fairly big chunk of this mega-volume came right at the open.
I'm surprised the stock didn't pop even higher with that amount of upward push.
What sparked this sudden stampede is (apparently) this...
Mind Medicine Stock Is Surging. A Student Who Made $110 Million Trading Bed Bath & Beyond Could Be Why
https://t.co/C3mEEjljdh
@unoyoya I was somewhat dismissive of #ketamine (at first) as well.
But as I learn more about its efficacy and as our despicable governments drag their heels on opening up other #psychedelics, I think all investors in #psychedelicstocks need ketamine exposure.
atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update
$ATAI announces a new $175 million loan facility, streamlines operations, and now has total cash/financing of $487 million.
#psychedelicstocks $CMPS $PSYK https://t.co/KyeUE97su6